The Big Tech earnings reporting season kicked off this afternoon with Meta, Microsoft and Tesla releasing quarterly results ...
Analysis published in the American Society of Nephrology highlighted strong evidence that ERAs benefit chronic kidney disease ...
More representative trial populations and standardized subgroup reporting are needed in non–small cell lung cancer (NSCLC) research, according to a meta-analysis published in Cancers, which found no ...
Long-term oral β-blocker therapy, including bisoprolol, metoprolol, and carvedilol, reduces the composite endpoint of all-cause death, new myocardial infarction, or heart failure by 25% in ...
Return on Assets (ROA): Meta Platforms's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.91%, the company may encounter challenges in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results